Palantir, Microchip Technology, and Arm Holdings are among the technology firms reporting this week, while pharmaceutical ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Investors' focus is likely to be on GILD???s HIV franchise performance and oncology sales when the company reports ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.21% of ...

Bullish option flow detected in Gilead (GILD) with 4,231 calls trading, 1.7x expected, and implied vol increasing almost 2 points to 28.65%.

Gilead Sciences (NASDAQ:GILD – Get Free Report) is scheduled to release its earnings data after the market closes on Wednesday, November 6th. Analysts expect Gilead Sciences to post earnings of $1.66 ...

For the first time, the Asia Pacific Chemsex Symposium (APCS) has moved from Taipei to Bangkok, marking a new chapter in its ...

In this article, we will take a look at the 10 Best Pharma Stocks To Buy Right Now.

Creative Financial Designs Inc. ADV boosted its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.4% during the third quarter, HoldingsChannel.com reports. The institutional investor ...

On Wednesday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $88.29 which represents a slight increase of $0.21 or 0.24% from the prior close of $88.08. The stock opened at ...

AbTherx announced the expansion of a previous agreement with Gilead (GILD) Sciences to develop novel antibody discovery technologies and ...

A former Gilead Sciences Inc. COO says in new court papers that a lawsuit filed against him by a former aide should be transferred to Ventura County, saying he had no personal or business ties to Los ...